Margaret Ann Pisani MD, MPH
Associate Professor of Medicine (Pulmonary); Program Director, Pulmonary and Critical Care Medicine Fellowship; Co-Director Sleep in the ICU Task Force
Sleep in critical illness
Current ProjectsSleep in the ICU
Treatment of ICU Delirium
Biomarkers for delirium
Outcomes of older ICU patients after critical illness
Outcomes of patients after rapid response team assessments
Outcomes after thoracic interventional procedures
Dr. Pisani performs clinical research in the field of pulmonary, critical care and sleep medicine. She has focused much of her research on outcomes in older intensive care unit patients. Specifically, she has looked at the prevalence of pre-existing cognitive impairment of patients admitted to the MICU and physician recognition of the impairment. She has also examined risk factors for poor outcomes from ICU care in older patients.
Her work has focused on predisposing risk factors as well as precipitating or modifiable risk factors such as medication use in the intensive care unit. She is interested in delirium, its pathogenesis, treatment and impact on outcomes.
She is currently studying sleep in an intensive care unit population. She is examining risk factors for sleep disruption, use of portable polysomnography in the ICU, and the impact of sleep deprivation on delirium and other ICU outcomes.
She is also examining the impact of rapid response team calls on older patients.
She also is a co-investigator in the Interventional Pulmonary (IP) research program where she provides expertise in clinical study design and data analysis. Projects from IP have included studies of the etiology of bilateral pleural effusions, safety of performing thoracentesis in patients with bleeding risks, impact of thoracentesis on dyspnea and quality of life, safety and tolerability of endobronchial ultrasound EBUS under conscious sedation and in obese patients.
Her studies have been funded by the Yale Pepper Center on Aging, American Lung Association, The Chest Foundation, The Hartford Foundation and Merck/American Federation on Aging Research and the NIH.